2001Unpublished venueRequires access

Specific Cellular and Humoral Immune Responses Induced by DMA Vaccine of HBV Surface Gene in Mice

DU Dewe, Jing Li

Open publisher page 0 citations

Abstract

To observe the specific immune responses and the protection against P815 mastocytoma cells stable expressing HbsAg in H-2d mice after immunized by DNA vaccine of HBV S gene. Methods: The immunization was performed by intramuscular injection of DNA and subcutaneous injection of P815-HBV-S. Serum anti-HBs was detected by ELISA. HbsAg secific cytotoxic T lymphocyte(CTL)activity was measured by 51 Chromium release assay. Results:The expression of HB-sAg was demonstrated by indirect immunofluorescent method. The 450nm A value of serum in immunized mice was 0.87. HBsAg specific CTL activity was 51.1%. HBV-SDNA vaccine could evidently inhibit the tumor growth,prolong the survival period( 38.2 d),and improve the survival rate. Conclusion: pCR3.1-S DNA vaccine has a strong antigenicity and marked killing effect to HBV infected cells in vivo.

About this research paper

What this paper is about

To observe the specific immune responses and the protection against P815 mastocytoma cells stable expressing HbsAg in H-2d mice after immunized by DNA vaccine of HBV S gene. Methods: The immunization was performed by intramuscular injection of DNA and subcutaneous injection of P815-HBV-S. Serum anti-HBs was detected by ELISA. HbsAg secific cytotoxic T lymphocyte(CTL)activity was measured by 51 Chromium release assay. Results:The expression of HB-sAg was demonstrated by indirect immunofluorescent method. The 450nm A value of serum in immunized mice was 0.87. HBsAg specific CTL activity was 51.1%. HBV-SDNA vaccine could evidently inhibit the tumor growth,prolong the survival period( 38.2 d),and improve the survival rate. Conclusion: pCR3.1-S DNA vaccine has a strong antigenicity and marked killing effect to HBV infected cells in vivo.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To observe the specific immune responses and the protection against P815 mastocytoma cells stable expressing HbsAg in H-2d mice after immunized by DNA vaccine of HBV S gene. Methods: The immunization was performed by intramuscular injection of DNA and subcutaneous injection of P815-HBV-S. Serum anti-HBs was detected by ELISA. HbsAg secific cytotoxic T lymphocyte(CTL)activity was measured by 51 Chromium release assay. Results:The expression of HB-sAg was demonstrated by indirect immunofluorescent method. The 450nm A value of serum in immunized mice was 0.87. HBsAg specific CTL activity was 51.1%. HBV-SDNA vaccine could evidently inhibit the tumor growth,prolong the survival period( 38.2 d),and improve the survival rate. Conclusion: pCR3.1-S DNA vaccine has a strong antigenicity and marked killing effect to HBV infected cells in vivo.

Key concepts: CTL*, HBsAg, Immunization, Immune system, Antigenicity, Virology, DNA vaccination, Cytotoxic T cell

Related papers

Back to paper searchBrowse research topicsOriginal source
Specific Cellular and Humoral Immune Responses Induced by DMA Vaccine of HBV Surface Gene in Mice — Research Paper | ScholarLens